194 related articles for article (PubMed ID: 37551870)
1. EPAC1 inhibition protects the heart from doxorubicin-induced toxicity.
Mazevet M; Belhadef A; Ribeiro M; Dayde D; Llach A; Laudette M; Belleville T; Mateo P; Gressette M; Lefebvre F; Chen J; Bachelot-Loza C; Rucker-Martin C; Lezoualch F; Crozatier B; Benitah JP; Vozenin MC; Fischmeister R; Gomez AM; Lemaire C; Morel E
Elife; 2023 Aug; 12():. PubMed ID: 37551870
[TBL] [Abstract][Full Text] [Related]
2. Novel Epac fluorescent ligand reveals distinct Epac1 vs. Epac2 distribution and function in cardiomyocytes.
Pereira L; Rehmann H; Lao DH; Erickson JR; Bossuyt J; Chen J; Bers DM
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):3991-6. PubMed ID: 25829540
[TBL] [Abstract][Full Text] [Related]
3. PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth.
Chen S; Chen J; Du W; Mickelsen DM; Shi H; Yu H; Kumar S; Yan C
Circ Res; 2023 Jul; 133(2):138-157. PubMed ID: 37232184
[TBL] [Abstract][Full Text] [Related]
4. Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardiac stress.
Laudette M; Coluccia A; Sainte-Marie Y; Solari A; Fazal L; Sicard P; Silvestri R; Mialet-Perez J; Pons S; Ghaleh B; Blondeau JP; Lezoualc'h F
Cardiovasc Res; 2019 Oct; 115(12):1766-1777. PubMed ID: 30873562
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
[TBL] [Abstract][Full Text] [Related]
6. The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1).
Courilleau D; Bouyssou P; Fischmeister R; Lezoualc'h F; Blondeau JP
Biochem Biophys Res Commun; 2013 Oct; 440(3):443-8. PubMed ID: 24099776
[TBL] [Abstract][Full Text] [Related]
7. Exchange protein directly activated by cAMP 1 promotes autophagy during cardiomyocyte hypertrophy.
Laurent AC; Bisserier M; Lucas A; Tortosa F; Roumieux M; De Régibus A; Swiader A; Sainte-Marie Y; Heymes C; Vindis C; Lezoualc'h F
Cardiovasc Res; 2015 Jan; 105(1):55-64. PubMed ID: 25411381
[TBL] [Abstract][Full Text] [Related]
8. Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.
Dhingra R; Rabinovich-Nikitin I; Rothman S; Guberman M; Gang H; Margulets V; Jassal DS; Alagarsamy KN; Dhingra S; Valenzuela Ripoll C; Billia F; Diwan A; Javaheri A; Kirshenbaum LA
Circulation; 2022 Sep; 146(12):934-954. PubMed ID: 35983756
[TBL] [Abstract][Full Text] [Related]
9. Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1 - mediated mitochondrial dysfunction.
Zhuang X; Sun X; Zhou H; Zhang S; Zhong X; Xu X; Guo Y; Xiong Z; Liu M; Lin Y; Zhang M; Liao X
Mech Ageing Dev; 2021 Apr; 195():111442. PubMed ID: 33539906
[TBL] [Abstract][Full Text] [Related]
10. Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses.
Okumura S; Fujita T; Cai W; Jin M; Namekata I; Mototani Y; Jin H; Ohnuki Y; Tsuneoka Y; Kurotani R; Suita K; Kawakami Y; Hamaguchi S; Abe T; Kiyonari H; Tsunematsu T; Bai Y; Suzuki S; Hidaka Y; Umemura M; Ichikawa Y; Yokoyama U; Sato M; Ishikawa F; Izumi-Nakaseko H; Adachi-Akahane S; Tanaka H; Ishikawa Y
J Clin Invest; 2014 Jun; 124(6):2785-801. PubMed ID: 24892712
[TBL] [Abstract][Full Text] [Related]
11. SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function.
Wang P; Wang L; Lu J; Hu Y; Wang Q; Li Z; Cai S; Liang L; Guo K; Xie J; Wang J; Lan R; Shen J; Liu P
J Mol Cell Cardiol; 2019 Aug; 133():125-137. PubMed ID: 31199952
[TBL] [Abstract][Full Text] [Related]
12. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
[TBL] [Abstract][Full Text] [Related]
13. COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis.
Zhang P; Lu H; Wu Y; Lu D; Li C; Yang X; Chen Z; Qian J; Ge J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373547
[TBL] [Abstract][Full Text] [Related]
14. Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro.
Wei S; Ma W; Yang Y; Sun T; Jiang C; Liu J; Zhang B; Li W
Biochem Pharmacol; 2023 Aug; 214():115662. PubMed ID: 37331637
[TBL] [Abstract][Full Text] [Related]
15. Serine mutations in overexpressed Hsp27 abrogate the protection against doxorubicin-induced p53-dependent cardiac apoptosis in mice.
Kanagasabai R; Karthikeyan K; Zweier JL; Ilangovan G
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H963-H975. PubMed ID: 34477462
[TBL] [Abstract][Full Text] [Related]
16. MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation.
Schirone L; Vecchio D; Valenti V; Forte M; Relucenti M; Angelini A; Zaglia T; Schiavon S; D'Ambrosio L; Sarto G; Stanzione R; Mangione E; Miglietta S; Di Bona A; Fedrigo M; Ghigo A; Versaci F; Petrozza V; Marchitti S; Rubattu S; Volpe M; Sadoshima J; Frati L; Frati G; Sciarretta S
Cell Mol Life Sci; 2023 Aug; 80(9):245. PubMed ID: 37566283
[TBL] [Abstract][Full Text] [Related]
17. Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.
Fang G; Li X; Yang F; Huang T; Qiu C; Peng K; Wang Z; Yang Y; Lan C
Phytomedicine; 2023 Aug; 117():154922. PubMed ID: 37321078
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.
Tadokoro T; Ikeda M; Ide T; Deguchi H; Ikeda S; Okabe K; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
JCI Insight; 2020 May; 5(9):. PubMed ID: 32376803
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis.
Kitakata H; Endo J; Ikura H; Moriyama H; Shirakawa K; Katsumata Y; Sano M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163335
[TBL] [Abstract][Full Text] [Related]
20. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
Li M; Sala V; De Santis MC; Cimino J; Cappello P; Pianca N; Di Bona A; Margaria JP; Martini M; Lazzarini E; Pirozzi F; Rossi L; Franco I; Bornbaum J; Heger J; Rohrbach S; Perino A; Tocchetti CG; Lima BHF; Teixeira MM; Porporato PE; Schulz R; Angelini A; Sandri M; Ameri P; Sciarretta S; Lima-Júnior RCP; Mongillo M; Zaglia T; Morello F; Novelli F; Hirsch E; Ghigo A
Circulation; 2018 Aug; 138(7):696-711. PubMed ID: 29348263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]